May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Gelatin Hydrogel as Controlled–Release Carrier of Growth Factor on Ocular Surface
Author Affiliations & Notes
  • K. Hori
    Ophthalmology, Kyoto Prefectural Univ of Med, Kyoto, Japan
  • C. Sotozono
    Ophthalmology, Kyoto Prefectural Univ of Med, Kyoto, Japan
  • K. Yamasaki
    Ophthalmology, Kyoto Prefectural Univ of Med, Kyoto, Japan
  • M. Ozeki
    Dept. of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
  • Y. Kimura
    Dept. of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
  • Y. Tabata
    Dept. of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
  • S. Kinoshita
    Ophthalmology, Kyoto Prefectural Univ of Med, Kyoto, Japan
  • Footnotes
    Commercial Relationships  K. Hori, None; C. Sotozono, None; K. Yamasaki, None; M. Ozeki, None; Y. Kimura, None; Y. Tabata, None; S. Kinoshita, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 2153. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Hori, C. Sotozono, K. Yamasaki, M. Ozeki, Y. Kimura, Y. Tabata, S. Kinoshita; Gelatin Hydrogel as Controlled–Release Carrier of Growth Factor on Ocular Surface . Invest. Ophthalmol. Vis. Sci. 2005;46(13):2153.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We have prepared several variations of biodegradable hydrogels from gelatin that has the ability to physicochemically interact with some growth factors, enabling their controlled release, have thereby successfully enhanced growth factor biological activities. Growth factor is released as a result of hydrogel degradation. The object of this study is to investigate the feasibility of using gelatin hydrogel for the controlled release of growth factor on the ocular surface. Methods: We used epidermal growth factor (EGF) as a representative growth factor. A biodegradable hydrogel was prepared from a cationic derivative of gelatin that can interact with EGF. The cationized gelatin hydrogel, with 125I–labelled EGF incorporated, was placed in the conjunctival sacs of mice, and the residual radiation was measured at different time intervals to evaluate the in vivo profile of EGF release. Hydrogel incorporating 5 µg of EGF was placed on a round defect of rabbit cornea (177 mm2) and the defect area was measured by image analyzing software to evaluate the healing process (n=6). In addition, epithelial proliferation was assessed immunohistochemically by counting the number of Ki67–positive cells. EGF–free cationized gelatin hydrogel was used as control. Results: Cationized gelatin hydrogel incorporating EGF remained over 7 days in the conjunctival sacs. When hydrogel incorporating EGF (E+) was applied to the corneal epithelial defect, defect area decreased to 10.0 ± 13.7 mm2 at 4 days after wounding; this was a significantly greater decrease than that seen with EGF–free hydrogel (E–) (49.3 ± 22.4 mm2) (p=0.01). The number of Ki67–positive cells at the peripheral unwounded cornea was 11 (E+) and 1.4 (E–) cells/mm. Conclusions: Cationized gelatin hydrogel is a promising carrier for controlled release of biologically active EGF on the ocular surface. This growth factor controlled–release system can be applied to other growth factors and may provide a novel treatment option for severe ocular surface diseases.

Keywords: cornea: basic science • growth factors/growth factor receptors • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×